Healthcare Triangle, INC

Healthcare Triangle, Inc. has issued over 12.5 million shares of common stock in connection with two M&A transactions, bolstering its market value and compliance with Nasdaq listing standards.

Healthcare Triangle, Inc. shareholders approved key proposals at the annual meeting, including director elections, auditor ratification, stock incentive plan amendments, and various share issuances.

Healthcare Triangle, Inc. enters into a securities exchange agreement to settle debt and amends a share purchase agreement for Teyame AI.

Healthcare Triangle, Inc. has closed a private placement of $4.235 million in senior convertible promissory notes, raising approximately $3.6 million in gross proceeds.

Healthcare Triangle, Inc. has entered into a material definitive agreement with SecureKloud Technologies Limited and its subsidiary Blockedge Technologies Inc. for the development of an integrated health advisory and care platform.

Healthcare Triangle, Inc. filed an amendment to its Form 8-K, providing the necessary financial statements for its recently acquired subsidiaries, Teyam 360 S.L. and Datono Mediacin S.L.

Healthcare Triangle, Inc. reported a 45% increase in Q3 2025 revenue and a significant improvement in its financial position, driven by strategic acquisitions and a successful capital raise, despite increased operating losses.

Healthcare Triangle, Inc. reported a 19% increase in Q2 2025 revenue to $3.56 million, alongside a strategic acquisition and improved liquidity, despite a significant drop in gross margin.

Healthcare Triangle's Q1 2025 revenue decreased by 10% year-over-year, with the company focusing on growing managed services and platform services for recurring revenue.

Healthcare Triangle experienced a substantial 69% decrease in revenue in the third quarter of 2024 compared to the same period last year, primarily due to the loss of a major customer and a strategic shift towards recurring revenue streams.

Healthcare Triangle, Inc. experienced a substantial 65% decrease in revenue in the second quarter of 2024 compared to the same period last year, prompting a strategic shift towards recurring subscription-based services.

Healthcare Triangle's Q1 2024 revenue decreased by 58% compared to the same period last year, primarily due to the loss of a major customer.

Healthcare Triangle, Inc. filed an amendment to its 2025 Annual Report to correct a clerical error in the independent auditor's signature.

Healthcare Triangle, Inc. announced its annual report for the fiscal year ended December 31, 2025, detailing a 19% increase in revenue to $13.9 million, driven by growth in Software Services.

Healthcare Triangle's 2024 annual report reveals a 65% revenue decrease, prompting a strategic shift towards managed and platform services to build recurring revenue.

Healthcare Triangle restated its 2023 financial statements due to insufficient audit procedures by the previous firm and identified a material weakness in internal controls.

Healthcare Triangle Inc. reported a 28% decrease in revenue for the full year 2023, alongside a net loss of $12.3 million.

Lakshmanan Kannappan, a business head at Healthcare Triangle, Inc., acquired 304,180 shares of common stock on March 31, 2025, through a distribution from the parent entity, SecureKloud Technologies, Inc.

Shibu Kizhakevilayil, Head of M&A at Healthcare Triangle, reports acquisition of 34,129 shares of common stock due to a distribution from SecureKloud Technologies.

Thyagarajan Ramachandran, CFO of Healthcare Triangle, Inc., acquired 14,627 shares of common stock as part of a share exchange transaction with SecureKloud Technologies, Inc.

SecureKloud Technologies distributed 2,550,000 shares of Healthcare Triangle, Inc. common stock to its shareholders via a share exchange transaction.

Director Mohammad Jainal Bhuiyan acquired 5,000 incentive stock options in Healthcare Triangle, Inc. on March 12, 2024.

Ronald W. McClurg, a director of Healthcare Triangle, Inc., acquired 5,000 incentive stock options on March 12, 2024, exercisable for common stock.

Healthcare Triangle, Inc. has issued a proxy statement for its 2026 Annual Meeting, seeking shareholder approval for multiple share issuances, equity plan amendments, and financing agreements.

Healthcare Triangle, Inc. is seeking stockholder approval for a reverse stock split to increase its share price and maintain its Nasdaq listing.

Healthcare Triangle, Inc. will hold a special meeting on November 28, 2025, to seek shareholder approval for future security issuances totaling up to $70 million to secure additional working capital.

Healthcare Triangle, Inc. announces its 2025 Annual Meeting of Stockholders to be held virtually on November 7, 2025, to elect directors and ratify its independent auditor.

Healthcare Triangle, Inc. announces the acquisition of Niyama Healthcare's cloud and technology assets and Ezovion Solutions, expanding its global healthcare IT footprint.

Healthcare Triangle, Inc. announces plans for a reverse stock split and an increase in authorized shares to maintain Nasdaq listing and enhance financial flexibility, approved by the Board and majority stockholders.

Healthcare Triangle, Inc. has filed a registration statement for the resale of up to 28 million shares of common stock by a selling stockholder.

Healthcare Triangle, Inc. is registering up to 1,483,809,885 shares of common stock for resale by selling stockholders, primarily stemming from recent private placements involving warrants with potentially significant dilution effects.

Healthcare Triangle, Inc. has filed an amendment to its Form S-1 registration statement to register up to 1,483,809,885 shares of common stock for resale by selling stockholders.

Healthcare Triangle, Inc. has filed a registration statement for the potential resale of up to 1,483,809,885 shares of its common stock by selling stockholders.

Healthcare Triangle, Inc. submits financial statements in XBRL format via Amendment No. 2 to its Form S-1 registration statement.

Healthcare Triangle, Inc. files an amendment to its S-1 registration statement to register up to 12,183,612 shares of common stock for resale by a selling stockholder, stemming from convertible notes and warrants.

Orca Capital AG has filed an amended Schedule 13G, reporting a passive beneficial ownership of 0.2% in Healthcare Triangle, Inc.

Multiple investment entities and John M. Fife have filed an amended Schedule 13G, reporting 0% beneficial ownership in Healthcare Triangle, Inc.

L1 Capital Global Opportunities Master Fund, Ltd. has increased its beneficial ownership in Healthcare Triangle, Inc. to 0.35% of common stock.

A group led by East West Capital, LLC has disclosed a 9.9% beneficial ownership stake in Healthcare Triangle, Inc., holding 821,286 common shares as of February 27, 2025.

L1 Capital Global Opportunities Master Fund, Ltd. has reported a beneficial ownership of 8.2% in Healthcare Triangle, Inc. common stock, acquired through the conversion of a convertible promissory note.